C-3PGUautologous cellular therapy, MSC-NTF cells, neurodegeneration
0-100 chain-logic scale · 15 dimensions · scored on public evidence
BrainStorm Cell presented the view that adult, patient-derived stem cells could be converted into therapeutic nerve-supporting cells and used to treat neurodegenerative disease by protecting injured neurons and helping restore neural function, positioning this as a practical alternative to embryonic stem-cell approaches.
SourceBrainStorm Cell Therapeutics states that it is developing adult stem cell therapies, using cells taken from a patient's own bone marrow, to treat currently incurable neurodegenerative diseases including Parkinson's disease, ALS, and multiple sclerosis. The company says these adult stem cells can be turned into healthy new brain-like cells that replace or support diseased cells, that NurOwn therapeutic cells are expected to enable rapid recovery and improved quality of life, and that its therapy may address underlying pathology rather than only symptoms.
SourceNo company-authored mission, belief statement, or scientific position is visible in the provided 2006-03-01 Wayback snapshot text; the visible content consists only of Internet Archive navigation and capture metadata, so no substantive company stance can be extracted from this snapshot alone.
Source